Journal of Cardiovascular Pharmacology

SEPTEMBER 25, 2023

Sepsis-induced cardiac dysfunction represents a major cause of high mortality in intensive care units with limited therapeutic options. Golgi protein 73 (GP73) has been implicated in various diseases. However, the role of GP73 in LPS-induced cardiac dysfunction is unclear. Here, we established sepsis-induced cardiac dysfunction model by LPS administration in wild type (WT) and GP73 knockout (GP73-/-) mice.

Article 40

Article 40

HeartRhythm

SEPTEMBER 25, 2023

In heart failure with reduced ejection fraction and heart failure with preserved ejection fraction, profound cellular and molecular changes have recently been documented in the failing myocardium.These changes include altered calcium handling and metabolic efficiency of the cardiac myocyte, reactivation of the fetal gene program, changes in the electrophysiological properties of the heart, and accumulation of collagen (fibrosis) at the interstitial level.Cardiac contractility modulation therapy

Preserved Ejection Fraction 40

Preserved Ejection Fraction Electrophysiology Heart Failure Document 40

Cardiovascular Ultrasound

SEPTEMBER 25, 2023

Carcinoid heart disease (CHD) caused by neuroendocrine tumours (NET) is associated with an increased morbidity and mortality due to valvular dysfunction and right sided heart failure. The present study aimed t.

Heart Disease 40

Heart Disease Heart Failure Research 40

HeartRhythm

SEPTEMBER 25, 2023

There has been a great evolution in pacemaker lead and technology from the initial pacemakers and leads that were originally available. With the first leads, any place in the heart that would allow good sensing and stimulation thresholds defined optimal lead placement. However, with advances in technology, the ability to pace a specific area or region of the heart has become available.

Pacemaker 40

Pacemaker Technology 40

Science Daily - Heart Disease

SEPTEMBER 25, 2023

With the ability to map dozens of biomarkers at once, a new method could transform testing for conditions including heart disease and cancer.

Biomarkers 40

Biomarkers Cancer Heart Disease 40

Cassling

SEPTEMBER 25, 2023

The new solution offers added visibility to support day-to-day operational excellence. Omaha, Neb. (September 25, 2023) — Cassling customers will have the option to access key analytics to ensure optimal performance of imaging equipment thanks to Clinsights™ Utilization Analytics from Glassbeam, a fleet-wide solution that tracks imaging system use, productivity and performance from the convenience of a single dashboard.

Technology 98

Technology Blog 98

Circulation

SEPTEMBER 25, 2023

Circulation, Ahead of Print. BACKGROUND:Immune checkpoint inhibitors (ICIs), antibodies targeting PD-1 (programmed cell death protein 1)/PD-L1 (programmed death-ligand 1) or CTLA4 (cytotoxic T-lymphocyte–associated protein 4), have revolutionized cancer management but are associated with devastating immune-related adverse events including myocarditis.

Cancer 40

Cancer Risk Factors Circulation 40